Inventor · disambiguated record
Lars Daniel Engstrom
Also filed as: ENGSTROM LARS DANIEL
6 granted patents·11 pending applications·3 citations·filing 2019–2025
69Inventor score
Files withMIRATI THERAPEUTICS INC17
Top patents by PatentIndex Score
17 records- 0184US12208099B2Combination therapiesMIRATI THERAPEUTICS INC·Filed 2019·Granted Jan 28, 2025·3 cites·9 claims
- 0274US2025073241A1Combination Therapies Using PRMT5 Inhibitors for the Treatment of CancerMIRATI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0373US2024423987A1Combination Therapies Using PRMT5 Inhibitors for the Treatment of CancerMIRATI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0471US2025108055A1Combination therapiesMIRATI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0570US12171765B2Combination therapies using PRMT5 inhibitors for the treatment of cancerMIRATI THERAPEUTICS INC·Filed 2022·Granted Dec 24, 2024·0 cites·18 claims
- 0670US12128048B2Combination therapies using PRMT5 inhibitors for the treatment of cancerMIRATI THERAPEUTICS INC·Filed 2022·Granted Oct 29, 2024·0 cites·16 claims
- 0766US12336995B2Combination therapiesMIRATI THERAPEUTICS INC·Filed 2019·Granted Jun 24, 2025·0 cites·36 claims
- 0862US2025262213A1Combination therapiesMIRATI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0959US2022040181A1Combination therapiesMIRATI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1059US2025213579A1Combination therapiesMIRATI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1159US2024398795A1Combination therapies using prmt5 inhibitors for the treatment of cancerMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1258US12485122B2Combination of palbociclib and adagrasib for lung cancerMIRATI THERAPEUTICS INC·Filed 2019·Granted Dec 2, 2025·0 cites·12 claims
- 1350US12377101B2Combination therapiesMIRATI THERAPEUTICS INC·Filed 2019·Granted Aug 5, 2025·0 cites·11 claims
- 1450US2025177399A1Combination therapiesMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1546US2025312343A1Combination therapies using prmt5 inhibitors and kras g12d inhibitors for the treatment of cancerMIRATI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1646US2025312351A1Combination therapies using prmt5 inhibitors and sos1 inhibitors for the treatment of cancerMIRATI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1746US2025312344A1Combination therapies using prmt5 inhibitors and immune checkpoint inhibitors for the treatment of cancerMIRATI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lars Daniel Engstrom files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →